Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,014 | 62,307 | 62,570 | 45,506 | 37,350 |
| Marketable Securities | 31,264 | 28,717 | 24,032 | 62,193 | 68,593 |
| Receivables | 47,461 | 41,380 | 43,136 | 34,351 | 37,705 |
| Inventories | 28,015 | 28,643 | 22,952 | 22,581 | 24,790 |
| Income taxes - deferred | 3,369 | 3,307 | 3,807 | 4,931 | 4,270 |
| Other current assets | 485 | 814 | 275 | 0 | 0 |
| TOTAL | $178,744 | $172,640 | $164,534 | $175,260 | $180,892 |
| Non-Current Assets | |||||
| PPE Net | 163,423 | 164,690 | 165,419 | 158,028 | 159,014 |
| Investments And Advances | 956 | 956 | 956 | 956 | 956 |
| Intangibles | 43,649 | 45,492 | 43,632 | 48,807 | 45,328 |
| Other Non-Current Assets | 5,193 | 4,476 | 4,260 | 3,603 | 708 |
| TOTAL | $213,221 | $215,614 | $214,267 | $211,394 | $206,006 |
| Total Assets | $391,965 | $388,254 | $378,801 | $386,654 | $386,898 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 260 | 260 | 9,917 | 9,900 | 4,546 |
| Accounts payable and accrued liabilities | 23,715 | 21,935 | 16,073 | 13,562 | 13,324 |
| Accrued Expenses | 303 | 303 | 303 | 4,196 | 314 |
| TOTAL | $33,415 | $34,147 | $36,607 | $36,369 | $32,222 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,482 | 13,482 | 4,080 | 4,080 | 10,509 |
| Deferred Revenues | 5,264 | 8,319 | 8,629 | 6,922 | 6,794 |
| Other Non-Current Liabilities | 191 | 191 | 191 | 191 | 290 |
| TOTAL | $24,965 | $24,325 | $14,731 | $15,717 | $21,053 |
| Total Liabilities | $58,380 | $58,472 | $51,338 | $52,086 | $53,275 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,471 | 31,708 | 31,726 | 32,616 | 32,966 |
| Common Shares | 353 | 352 | 352 | 351 | 350 |
| Retained earnings | 187,675 | 180,672 | 174,995 | 170,256 | 171,100 |
| Other shareholders' equity | -64 | 4,751 | 5,537 | 4,976 | 3,899 |
| TOTAL | $333,585 | $329,782 | $327,463 | $334,568 | $333,623 |
| Total Liabilities And Equity | $391,965 | $388,254 | $378,801 | $386,654 | $386,898 |